Mortgage Proposals and Rate Swings: A Housing Market in Search of Real Solutions
As mortgage rates fluctuate and ambitious policy ideas emerge, economists warn that financing tweaks cannot solve the core issue: a chronic shortage of homes.
IT Services Sector
Showing 3951 articles
Business
Kimberly-Clark Shares Get a Lift as UBS Analyst Raises Price Target Following Solid Earnings
UBS analyst Peter Grom increased his price target for Kimberly-Clark (KMB) to $110, citing steady core performance despite lingering Kenvue-related uncertainties, after the consumer goods giant reported better-than-expected quarterly profit driven by cost discipline and resilient demand.
Business
Stifel Trims Altria Price Target Amid Cost Pressures, Maintains Buy on Dividend Strength
Stifel Nicolaus lowered its price target on Altria Group (MO) by $4 to $68, citing higher-than-expected operating costs. Despite near-term headwinds, the firm reaffirmed its Buy rating, pointing to the tobacco giant's resilient dividend profile and long-term earnings guidance.
Business
Precious Metals Rout Rattles Global Markets as Investors Seek Shelter
A sharp sell-off in gold and silver, alongside falling oil prices, has sparked volatility across global markets at the start of a week packed with major earnings and central bank decisions.
Business
Disney Posts Strong Q1 Earnings Amid CEO Succession Speculation
The Walt Disney Company exceeded Wall Street expectations in its fiscal first quarter, delivering robust results across its entertainment, experiences, and streaming divisions as longtime CEO Bob Iger prepares to hand over the reins later this year.
Business
Gold's Sharp Retreat: A Pause in the Safe-Haven Rally or a Sign of Things to Come?
After a historic surge, gold prices have experienced their steepest drop in decades. Yet, analysts point to enduring geopolitical tensions and monetary policy shifts as reasons why the metal's long-term appeal remains intact.
New Year's Financial Resolutions Already Fading? Five Actionable Steps to Regain Control in 2026
If your 2026 financial goals have already lost momentum, you're not alone. Experts suggest shifting focus to specific, automated strategies and building resilient habits to secure your economic future.
Business
Insiders Bet Big: Three Undervalued Small-Caps Poised for a Turnaround in February 2026
Amid a mixed market landscape, corporate insiders are placing significant bets on select small-cap stocks. We analyze three companies where recent insider buying and strategic moves signal potential value, despite broader economic headwinds.
Business
Market Watch: Three Undervalued Stocks Trading at Steep Discounts to Intrinsic Value
Amid a choppy market landscape in early 2026, value investors are scanning for opportunities. We analyze three companies—Viavi Solutions, Kontoor Brands, and Robert Half—whose current share prices appear significantly disconnected from their estimated intrinsic worth based on cash flow projections.
US
Mexico's Education Secretary Mourns as Kin Slain in Colima Home Invasion; Three Suspects Killed in Police Raid
The aunt and cousin of Mexico's Secretary of Public Education, Mario Delgado, were fatally shot in their Colima home. Authorities later killed three suspects in a confrontation, highlighting the persistent violence plaguing the region.
Business
Istanbul Fashion Connection 2026 Set to Welcome 30,000 Global Buyers, Cementing Turkey's Role as a Fashion Hub
The ninth edition of the Istanbul Fashion Connection (IFCO) is poised to gather an estimated 30,000 trade visitors and 400 exhibitors this February, highlighting Turkey's expanding influence in the global apparel sourcing landscape.
Navigating Medicare's Maze: Three Costly Misconceptions Retirees Must Unlearn
Millions rely on Medicare, yet common misunderstandings about its coverage rules and costs can lead to significant financial shocks in retirement. We clarify three critical areas where assumptions often prove wrong.
Business
Oracle Bets Big on Cloud: Tech Giant Seeks $50 Billion to Fuel AI Infrastructure Race
Oracle announces plans to raise up to $50 billion in 2026 through debt and equity to massively expand its cloud data centers, aiming to meet surging demand from AI leaders like Nvidia, OpenAI, and xAI.
Business
Rhythm Pharmaceuticals: The Under-the-Radar Biotech Outpacing Tech Giants
While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.
World
Iran Detains Four Foreign Nationals Amid Post-Protest Crackdown
Iranian authorities announced the arrest of four foreigners allegedly involved in last month's widespread unrest, seizing homemade explosives in the operation as the government continues to blame external actors for domestic turmoil.
Business
BeOne Medicines Deepens InSysBio Modeling Partnership to De-Risk Oncology Pipeline
BeOne Medicines extends its collaboration with quantitative systems pharmacology firm InSysBio, aiming to optimize clinical trial dosing and mitigate cytokine release syndrome risks across its broad portfolio of 15 novel oncology assets.
Business
Under Armour at a Crossroads: Major Shareholder Buys In Amid Legal Setback and Executive Departure
Under Armour faces a pivotal moment as a significant insider purchase coincides with a high-stakes legal loss and the exit of its Chief Product Officer, testing investor confidence in the embattled sportswear brand's turnaround strategy.
Business
Cogent Biosciences Gains Key FDA Designations for Bezuclastinib, Spotlighting GIST Treatment Potential
Cogent Biosciences secures FDA Breakthrough Therapy Designation and enters the Real-Time Oncology Review program for its lead drug candidate bezuclastinib in gastrointestinal stromal tumors (GIST), marking significant regulatory momentum for the biotech firm.
Business
Empire State Realty Trust: A Valuation Puzzle as P/E and Fair Value Tell Conflicting Stories
Shares of Empire State Realty Trust (ESRT) are trading at $6.63, presenting investors with a conundrum: a narrative suggesting undervaluation clashes with a premium price-to-earnings multiple. We examine the divergence and what it means for the iconic property owner.
Business
InflaRx's Cash Runway Narrows: Can the Biotech Steer Through Financial Headwinds?
With a cash reserve that could last just over a year at its current burn rate, InflaRx faces a critical period to prove its clinical pipeline's value. While management has reined in spending, the company's financial strategy is now under the microscope.